图书馆订阅: Guest
肿瘤形成评论综述™

每年出版 4 

ISSN 打印: 0893-9675

ISSN 在线: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Liquid Biopsies in the Screening of Oncogenic Mutations in NSCLC and its Application in Targeted Therapy

卷 20, 册 5-6, 2015, pp. 357-371
DOI: 10.1615/CritRevOncog.v20.i5-6.90
Get accessGet access

摘要

Non-small cell lung cancer (NSCLC) still dominates cancer-related deaths in America. Despite this, new discoveries and advancements in technology are helping with the detection and treatment of NSCLC. The discovery of circulating tumor DNA in blood and other biofluids is essential for the creation of a DNA biomarker. Limitations in technology and sequencing have stunted assay development, but with recent advancements in the next-generation sequencing, droplet digital PCR, and EFIRM, the detection of mutations in biofluids has become possible with reasonable sensitivity and specificity. These methods have been applied to the detection of mutations in NSCLC by measuring the levels of circulating tumor DNA. ALK fusion genes along with mutations in EGFR and KRAS have been shown to correlate to tumor size and metastasis. These methods allow for noninvasive, affordable, and efficient diagnoses of oncogenic mutations that overcome the issues of traditional biopsies. These issues include tumor heterogeneity and early detection of cancers with asymptomatic early stages. Early detection and treatment remain the best way to ensure survival. This review aims to describe these new technologies along with their application in mutation detection in NSCLC in order to proactively utilize targeted anticancer therapy.

对本文的引用
  1. Ahmad-Nejad Parviz, Ashavaid Tester, Vacaflores Salinas Aldo, Huggett Jim, Harris Kathryn, Linder Mark W., Baluchova Katarina, Steimer Werner, Payne Deborah A., Current and future challenges in quality assurance in molecular diagnostics, Clinica Chimica Acta, 519, 2021. Crossref

  2. Baburaj Gayathri, Damerla Rama Rao, Udupa Karthik S, Parida Preetiparna, Munisamy Murali, Kolesar Jill, Rao Mahadev, Liquid biopsy approaches for pleural effusion in lung cancer patients, Molecular Biology Reports, 47, 10, 2020. Crossref

  3. Gattuso Giuseppe, Crimi Salvatore, Lavoro Alessandro, Rizzo Roberta, Musumarra Giorgia, Gallo Simona, Facciponte Flavia, Paratore Sabrina, Russo Angela, Bordonaro Roberto, Isola Gaetano, Bianchi Alberto, Libra Massimo, Falzone Luca, Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions, Non-Coding RNA, 8, 4, 2022. Crossref

  4. Guo Qianqian, Liu Liwei, Chen Zelong, Fan Yannan, Zhou Yang, Yuan Ziqiao, Zhang Wenzhou, Current treatments for non-small cell lung cancer, Frontiers in Oncology, 12, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain